Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect.

Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect.

OBJECTIVE: To determine the prevalence of ankylosing spondylitis in the Fula ethnic group in The Gambia, and relate the disease prevalence to the B27 frequency and subtype distribution of that population. METHODS: 215 first degree relatives of 48 B27 positive Fula twin pairs, and 900 adult Fula male...

Descripció completa

Dades bibliogràfiques
Autors principals:	Brown, M, Jepson, A, Young, A, Whittle, H, Greenwood, B, Wordsworth, B
Format:	Journal article
Idioma:	English
Publicat:	1997

Ítems similars

Ankylosing spondylitis in west Africans - evidence for a non-HLA-B*27 protective effect - reply
per: Brown, M, et al.
Publicat: (1997)

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect - Reply
per: Brown, M, et al.
Publicat: (1998)

Spondyloarthritis in the Gambia - Evidence for a non-HLA B27 protective effect.
per: Brown, M, et al.
Publicat: (1996)

HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.
per: Brown, M, et al.
Publicat: (1996)

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect.
per: van der Linden, S, et al.
Publicat: (1998)

Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis
per: Jessika Nordin, et al.
Publicat: (2021-07-01)

Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
per: Jaakkola, E, et al.
Publicat: (2006)

MHC class II and III genes are associated with ankylosing spondylitis independent of HLA-B27.
per: Sims, A, et al.
Publicat: (2004)

The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis
per: A. Cauli, et al.
Publicat: (2002-09-01)

Mapping of MHC class II and III genes associated with Ankylosing spondylitis independent of HLA-B27
per: Sims, A, et al.
Publicat: (2005)

Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
per: Orchard, T, et al.
Publicat: (1997)

Non-B27 MHC associations of ankylosing spondylitis.
per: Sims, A, et al.
Publicat: (2007)

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
per: Robinson, P, et al.
Publicat: (2015)

The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis.
per: Brown, M, et al.
Publicat: (1998)

Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment.
per: Brown, M, et al.
Publicat: (1997)

Genetics of ankylosing spondylitis.
per: Brown, M, et al.
Publicat: (2002)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

Genetic susceptibility to ankylosing spondylitis.
per: Sims, A, et al.
Publicat: (2004)

MAPPING THE NON-B27 MHC ASSOCIATIONS OF ANKYLOSING SPONDYLITIS (AS)
per: Sims, A, et al.
Publicat: (2004)

MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions
per: Geng Wang, et al.
Publicat: (2020-04-01)

The role of ERAP1 and HLA-B27 in ankylosing spondylitis pathogenesis
per: Chen, L
Publicat: (2013)

Determination of HLA-B27 Subtypes in Iranian Patients with Ankylosing Spondylitis
per: Mohamad Hossein Nicknam, et al.
Publicat: (2008-03-01)

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.
per: Brown, M, et al.
Publicat: (1996)

Susceptibility to ankylosing spondylitis.
per: Carter, N, et al.
Publicat: (2000)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
per: Evans, D, et al.
Publicat: (2011)

Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients
per: Matthew L. Stoll, et al.
Publicat: (2022-04-01)

ANKYLOSING-SPONDYLITIS AND FUNCTIONAL ABILITY
per: Wordsworth, B, et al.
Publicat: (1984)

Clinical picture of ankylosing spondylitis in HLA-B27 positive and negative patients
per: Sh. F. Erdes, et al.
Publicat: (2023-10-01)

Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
per: Joachim Sieper, et al.
Publicat: (2023-08-01)

Predominant frequency of HLA‐B*27 in patients with ankylosing spondylitis in southeastern China
per: JiaoJiao Lu, et al.
Publicat: (2021-12-01)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
per: Rysnik, O, et al.
Publicat: (2012)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
per: Evans, D, et al.
Publicat: (2011)

The X-chromosome and susceptibility to ankylosing spondylitis.
per: Hoyle, E, et al.
Publicat: (2000)

Interleukin-1 and susceptibility to ankylosing spondylitis
per: Edwards, S, et al.
Publicat: (2001)

Secretor status and ankylosing spondylitis.
per: Pal, A, et al.
Publicat: (1998)

Hypophosphataemia masquerading as ankylosing spondylitis
per: Wordsworth, B, et al.
Publicat: (2008)

Ankylosing spondylitis without B27: no evidence for gene conversion.
per: Pease, C, et al.
Publicat: (1988)

Investigation of the role of ANKH in ankylosing spondylitis.
per: Timms, A, et al.
Publicat: (2003)

The role of NK family receptor interactions with HLA-B27 in Ankylosing Spondylitis pathogenesis
per: Giles, J
Publicat: (2011)